
Lenz
LENZ Therapeutics is is a late-stage clinical company developing innovative ophthalmic pharmaceutical products that improve vision, focused on an eye drop to treat presbyopia and provide seamless vision for the vast majority of presbyopes.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredApr 27, 2021 (5 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Founders and team
JM
James McCollum Foundersource: lenz-tx.com
Companies like Lenz
CClaris Bio$118M Series B+ · Jul 2026
BBiossil$153M Seed · Sep 2026
LLUCA Science$30M Series B+ · Jun 2022AAstrocyte Pharmaceuticals$9.5M Series B+ · Sep 2026
EEpilepsy GTx$33M Series A · Dec 2025
SSimmunome AI
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/lenz (get a free API key).